X-linked retinoschisis maculopathy treated with topical dorzolamide, and relationship to genotype.
X-linked retinoschisis maculopathy treated with topical dorzolamide, and relationship to genotype.
Topical dorzolamide may have some effect in reducing central macular thickness in patients with XLRS, but this does not necessarily correlate with improvement in VA. In our case series, genotypic information did not predict the response to this treatment
922-928
Khandhadia, Sam
a84355f9-8dd3-4377-864f-27fa059ad847
Trump, D.
3bf4960e-1b72-4a77-929e-7179f9d991b5
Menon, G.
36fcc284-6e4e-4885-a6f2-c3c7af8c58cd
Lotery, A.J.
5ecc2d2d-d0b4-468f-ad2c-df7156f8e514
July 2011
Khandhadia, Sam
a84355f9-8dd3-4377-864f-27fa059ad847
Trump, D.
3bf4960e-1b72-4a77-929e-7179f9d991b5
Menon, G.
36fcc284-6e4e-4885-a6f2-c3c7af8c58cd
Lotery, A.J.
5ecc2d2d-d0b4-468f-ad2c-df7156f8e514
Khandhadia, Sam, Trump, D., Menon, G. and Lotery, A.J.
(2011)
X-linked retinoschisis maculopathy treated with topical dorzolamide, and relationship to genotype.
Eye, 25 (7), .
(doi:10.1038/eye.2011.91).
(PMID:21527955)
Abstract
Topical dorzolamide may have some effect in reducing central macular thickness in patients with XLRS, but this does not necessarily correlate with improvement in VA. In our case series, genotypic information did not predict the response to this treatment
This record has no associated files available for download.
More information
e-pub ahead of print date: 29 April 2011
Published date: July 2011
Organisations:
Clinical & Experimental Sciences
Identifiers
Local EPrints ID: 338859
URI: http://eprints.soton.ac.uk/id/eprint/338859
ISSN: 0950-222X
PURE UUID: c1d5daf4-1221-4e3b-8ba9-3063ceca4e31
Catalogue record
Date deposited: 18 May 2012 08:12
Last modified: 15 Mar 2024 03:15
Export record
Altmetrics
Contributors
Author:
Sam Khandhadia
Author:
D. Trump
Author:
G. Menon
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics
